...
首页> 外文期刊>Clinical imaging >Fusion of PET and MRI for staging of uterine cervical cancer: Comparison with contrast-enhanced 18F-FDG PET/CT and pelvic MRI
【24h】

Fusion of PET and MRI for staging of uterine cervical cancer: Comparison with contrast-enhanced 18F-FDG PET/CT and pelvic MRI

机译:PET和MRI融合治疗宫颈癌分期:与对比增强的18F-FDG PET / CT和骨盆MRI进行比较

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To investigate the fusion of pelvic magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (PET) for assessment of locoregional extension and nodal staging of cervical cancer. Methods: PET/computed tomography (CT), MRI, and non-fused and fusion of PET and MRI for assessing the extent of the primary tumor and metastasis to nodes were evaluated. Results: Accuracy for T-status was 83.3% for fused and non-fused PET/MRI and MRI proved significantly more accurate than PET/CT (53.3%) (P= .0077). Sensitivity, specificity, and accuracy for nodal metastasis were 92.3%, 88.2%, and 90.0% for fused PET/MRI and PET/contrast-enhanced CT; 84.6%, 94.1%, and 90.0% for non-fused PET/MRI; and 69.2%, 100%, and 86.7% for MRI. Conclusion: Fused PET/MRI combines the individual advantages of MRI and PET.
机译:目的:研究骨盆磁共振成像(MRI)和氟脱氧葡萄糖正电子发射断层扫描(PET)的融合,以评估子宫颈癌的局部区域扩展和淋巴结分期。方法:评估PET /计算机断层扫描(CT),MRI以及非融合和PET与MRI融合以评估原发肿瘤的程度和转移至淋巴结的情况。结果:融合和非融合PET / MRI的T形状态准确度为83.3%,而MRI被证明比PET / CT准确率(53.3%)显着更高(P = .0077)。融合PET / MRI和PET /增强CT对淋巴结转移的敏感性,特异性和准确性分别为92.3%,88.2%和90.0%。非融合PET / MRI的84.6%,94.1%和90.0%; MRI分别为69.2%,100%和86.7%。结论:融合PET / MRI融合了MRI和PET的独特优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号